Home > Insider Trading > Filing (0001062993-22-023884)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1479681	Nutex Health Inc.	NUTX	Services-Business Services, Nec (7389)	113363609

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1920021	Premier Macy Management Holdings, Llc	6030 S. Rice Ave., Suite C Houston TX 77081		No	No	Yes	No
1920043	Stephen Matthew Young	6030 S. Rice Ave., Suite C Houston TX 77081		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2022-12-12	125,498	$2.21	42,008,712	No	4	S	Direct
Class A Common Stock	Disposition	2022-12-13	43,880	$2.06	41,964,832	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by Premier Macy Management Holdings, LLC ("Premier").
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.04 to $2.445, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.
Premier is the direct beneficial owner of the securities reported herein. Matthew Stephen Young is the managing member of Premier and a director of Nutex Health, Inc. Mr. Young disclaims beneficial ownership of any securities that exceed his pecuniary interest in Premier.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.04 to $2.12, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2.